Medtronic: raises annual targets

(CercleFinance.com) - On its quarterly results, Medtronic has announced that it is raising its targets for 2023-24, now anticipating adjusted EPS of $5.
19 to $5.21 and organic sales growth of 4.75% to 5%.

The medical equipment supplier posted Q3 non-GAAP EPS of $1.30 on sales of $8.1bn, up 4.7% (+4.6% in organic terms).

Our recent major product approvals, including in diabetes and heart rhythm, reinforce our confidence in generating reliable growth over the coming quarters and years, management said.


Copyright (c) 2024 CercleFinance.com. All rights reserved.